top of page

Search Results

Search results for "neuroimmune signaling"

Results found for "neuroimmune signaling"

  • Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem

    proteins, and cytoskeletal components, and those interactions reshape conformation, ligand binding, and signaling developed BRET and NanoBRET-based live-cell platforms that capture protein-protein interactions and signaling His research centers on GPCR functional interactions, with a focus on arrestin signaling, receptor complex Bias Signaling Is a Kinetic Problem, Not Just a Pathway Problem Spider plots comparing signaling bias For Pfleger, the reach of the technology is not a source of pride as much as a signal that the field

  • Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem

    computational protein design, hybrid GPCR constructs, and how computational pipelines can accelerate GPCR signaling These hybrid receptors enable researchers to probe receptor signaling, investigate G protein coupling Listeners gain insight into how computational protein design can accelerate receptor signaling research This strategy can reveal signaling pathways or structural features of orphan GPCRs that cannot easily Yamina Berchiche: So you can essentially probe the signaling pathways of receptors that are otherwise

  • Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem

    Industrial GPCR Pharmacology Scientific Abstract This conversation traces how GPCR pharmacology, receptor signaling , the identification of receptor activity-modifying proteins (RAMPs), and the realization that CGRP signaling The discovery of RAMPs was only possible because the assay tied receptor signaling to a highly amplified Apart from APOE4 in Alzheimer’s disease, most signals failed to reach robustness with available cohort at GSK, expectations for GPCR target discovery from association studies, and reflections on why many signals

  • Dr. Bianca Plouffe | Dr. GPCR Ecosystem

    She identified the structural determinant controlling biased signaling of melatonin type 2 receptors which led to the finding that both β-arrestin and G protein can simultaneously bind to some GPCRs when signaling Funded by a Wellcome Trust Seed Award, she investigated biased and compartmentalized G protein signaling Her subsequent work has focused on understanding the role of compartmentalized Gq signaling by the cytomegalovirus-encoded

  • Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem

    If the right ligand could engage G-protein signaling while sparing β-arrestin, pain relief might finally Her lab now studies δ- and μ-opioid receptor signaling, biased agonism, receptor trafficking and recycling Even as the field pushes toward iPSC-derived somatic systems, HEK-cell signaling profiles of μ-opioid Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling , trafficking, and their ability to activate different signaling pathways and signaling bias.

  • Nicole Perry-Hauser | Dr. GPCR Ecosystem

    My long-term research interests involve resolving signaling pathways downstream of aGPCRs and establishing how/if these receptors’ adhesive properties influence signaling events, and in turn, whether signaling

  • Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem

    I then undertook my first project where I demonstrated that MRAP2 regulates the signaling of multiple Concurrently, I described the mechanisms by which MRAP2 regulates GHSR1a signaling; this project brought Using this novel technique, I showed that MRAP2 biased GHSR1a signaling and shut down its constitutive activity; this work resulted in a first author publication in Science Signaling. to create a scientific session at the American Physiology Summit (APS) 2024 dedicated to GPCR biased signaling

  • Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem

    spanned chemokine receptor conformational dynamics at the Université de Montréal, CXCR3 splice-variant signaling Tom Sakmar's lab, where she characterized the signaling diversity of three alternative splice variants Splice variants aren't just structural — they signal differently. question from Tom Sakmar, demonstrated that variants encoded by the same gene can recruit different signaling The implication: transcript-level diversity is itself a signaling mechanism, not a cloning artifact to

  • Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem

    His current work extends that logic into signaling kinetics: the time dimension in GPCR signaling that independent research focuses on developing accessible mathematical tools for kinetic analysis of GPCR signaling Receptor residence time as a determinant of in vivo drug efficacy — and why affinity alone is insufficient Signaling Yet that is precisely how most labs treat time-course signaling data — collecting it, plotting it, and To me, that's what we've been doing with time-course signaling data."

  • Dr. Paul J. Gasser | Dr. GPCR Ecosystem

    Gasser " I received my BS and MS in Zoology & Physiology at the University of Wyoming, where I studied signaling Lowry's lab, examined the role of organic cation transporter 3 (OCT3) in the regulation of monoamine signaling Research in my lab is currently focused on understanding the signal transduction pathways activated by

  • Dr. Benjamin Myers | Dr. GPCR Ecosystem

    His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford

  • GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem

    How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes Why strategic flexibility in exploring non-canonical signaling pathways is critical for GPCR-targeted Researchers refining strategies for high-throughput screening or exploring biased signaling. fellowship at GSK, where he entered the GPCR field and became proficient in aptamer selection and cell signaling

  • FAQ | Dr. GPCR Ecosystem

    live online scientific sessions focused on G protein-coupled receptor (GPCR) biology, pharmacology, signaling entering drug discovery If you work directly with receptor systems, ligand design, efficacy modeling, or signaling These webinars are designed for scientists with foundational knowledge in receptor pharmacology, signaling operational models Allosteric modulators (PAMs and NAMs) Biased agonism Dose–response modeling Calcium and signaling

  • Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem

    NIDDK) - NIH, USA as a postdoctoral fellow and trained on understanding the physiological role of GPCR signaling GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D) by exploring metabolically important signaling Sai Prasad Pydi on the web Molecular Metabolism & Cell Signaling Laboratory Website Twitter.com Research

  • Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem

    Silvio Gutkind, who has spent more than three decades pushing GPCRs as oncogenic signaling systems, the continued at the NIH across neurobiology and oncogenes, and grew into a multi-decade program on GPCR signaling GαS, Gα13) GαQ-driven uveal melanoma and the limits of the canonical PLC pathway Non-canonical GαQ signaling Non-canonical signaling opened a new drug target. In this episode, Silvio discusses G protein signaling in the context of cancer, immunotherapies, and

  • Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem

    Unexpected data is the signal, not the noise A line Bouvier returns to throughout his career, originally - landing the postdoc that changed the trajectory 12:06 The meaning of unexpected data and what it signals Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones

  • Dr. GPCR Board | Dr. GPCR Ecosystem

    research program is to gain a thorough and mechanistic understanding of processes that control cell signaling The precise control of PAR signaling is critical for proper temporal and spatial dynamics of signaling Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors signaling of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling

  • Dr. Davide Calebiro | Dr. GPCR Ecosystem

    engineers and computer scientists focusing on the basic mechanisms of G protein-coupled receptor (GPCR) signalling To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule microscopy, which allow them to directly observe signalling events in living cells and tissues with

  • Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem

    missing pharmacology of ~100 unassigned receptors GPCRs in oncology, immunology, and microbiome-host signaling Marshall's team at GSK cloned GABA-B1, tried to get it to signal, and couldn't. Marshall in the room — a new category of GPCR biology opened, with heterodimers as obligate signaling The shift came through the tumor microenvironment — immune cells, chemokine receptors, adenosine signaling readability. 00:00 Welcome and guest introduction 02:32 How an undergraduate lecture on β-adrenergic signaling

  • Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem

    His work is central to the quantitative framework used today to describe receptor signaling bias, allosteric He proposed one of the first mechanistic explanations of biased signaling and co-authored the widely He is the author of A Pharmacology Primer, Editor-in-Chief of the Journal of Receptors and Signal Transduction short-form mechanistic discussions, and ongoing dialogue with the GPCR community on receptor theory, biased signaling

  • Dr. Randy Hall | Dr. GPCR Ecosystem

    the past two decades, his lab has published numerous groundbreaking findings shedding light on the signaling Most recently, his lab has made a number of seminal contributions to understanding the signaling, regulation has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor signaling

  • EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem

    scientists audit what AI can and can't do for GPCR drug discovery — from orphan receptors and biased signaling years in early R&D at Novo Nordisk before turning to systems biology approaches for connecting in vitro signaling mathematician and computer scientist, his doctoral work focused on developing new methods for modeling GPCR signaling computational cost of molecular dynamics simulations needed to capture the dynamic conformations behind signaling 37:01 Reading GPCR signaling dynamics with computational models 39:53 Generative models, scoring functions

  • Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem

    Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and has demonstrated that mood stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target signaling is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling

  • Dr. Lauren M. Slosky | Dr. GPCR Ecosystem

    These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling , they are exciting tools for linking distinct signaling pathways with their physiological effects and

  • Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem

    projects, I studied the role of β-arrestin in G protein trafficking, the impact of GPCR ubiquitination on signaling My current research focuses on investigating GPCR signaling and trafficking in the context of inflammation I am particularly interested in spatial signaling bias or how GPCRs can redistribute to different subcellular compartments to trigger distinct signaling events. " Dr. Badr shared his passion for GPCR signalling and regulation, specifically in the context of pain and inflammation

  • Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem

    she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling fundamental cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling Caroline continued to undertake postdoctoral research in Oxford, investigating the signalling and trafficking

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and Thomas Sakmar’s laboratory at The Rockefeller University, where she study’s the signaling and degradation She is currently working to understand the signaling and degradation of GPCRs in disease states to help

  • Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem

    diabetes, and muscarinic receptors, her lab screens in disease-relevant cell lines and looks early for signaling beta-arrestin activity at a wild-type FFA2 receptor, suppressible by an inverse agonist that then redirects signaling receptor actually encounters in disease tissue - effectors like Go or Gz that are critical in neuronal signaling that made the G-protein bind better, some of which trapped the receptor in a state where it could not signal Is a 20% reduction of beta-arrestin signaling enough? I think it is probably cell-dependent.

bottom of page